Comparing two wound dressings for hidradenitis suppurativa surgery
Part of Infections, Skin clinical trials.
This study compares two wound dressings used after surgery for hidradenitis suppurativa (HS) to see which one helps wounds heal better. It may help if you need a wide surgical excision for HS and can attend follow-up visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have a confirmed diagnosis of hidradenitis suppurativa that requires surgery to remove a large area of affected skin.
- You can understand and sign a consent form in English.
- You are willing and able to come to all scheduled follow-up appointments until the wound is ready for a second surgical closure.
- You are not allergic to any of the wound dressing materials (polyvinyl alcohol), local anesthetics, or silver.
- You do not have medical conditions that make lidocaine unsafe for you, such as certain heart problems.
- You are not pregnant or breastfeeding.
- You do not have severe immune system suppression (e.g., recent chemotherapy, organ transplant, uncontrolled HIV, or high-dose steroids).
- Your diabetes is well-controlled (HbA1c of 10% or lower if tested in the last 3 months).
- You do not have an active infection or sepsis at the time of surgery.
- You can commit to all follow-up visits until the second stage of wound closure is complete.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing an experimental tablet called LT-002-158 in adults with moderate to severe hidradenitis suppurativa (HS) that hasn't improved enough with standard treatments. The goal is to see if it's safe and helps reduce painful lumps and abscesses.
This trial tests a new medicine called SCT650C for people with moderate to severe hidradenitis suppurativa (HS). The goal is to see if it can reduce painful bumps and abscesses better than current treatments.
This study looks at certain immune cells (called MAIT cells) in the skin of people with hidradenitis suppurativa, a painful skin condition. It will compare samples from people before they start a new biologic treatment, and may help doctors understand how these treatments work.
This trial tests a new cream (EVO101) for people with mild to moderate hidradenitis suppurativa (HS), a skin condition causing painful lumps. It aims to see if the cream can reduce the number of lesions. Participants cannot use certain other HS treatments during the study.
This trial tests a 1726-nm laser to reduce inflamed nodules in people with mild to moderate hidradenitis suppurativa (HS). It compares treated and untreated areas to see if the laser helps without affecting the rest of the body.
This study tests whether applying secukinumab as a topical cream or as a subcutaneous injection is more effective and safer for treating hidradenitis suppurativa (a skin condition causing painful lumps). It aims to find a better way to manage symptoms in people whose condition has not improved with standard treatments.
Hear when a new Hidradenitis Suppurativa (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.